Mierzhati Mushajiang

1.3k total citations
6 papers, 547 citations indexed

About

Mierzhati Mushajiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mierzhati Mushajiang has authored 6 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Mierzhati Mushajiang's work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (5 papers) and HER2/EGFR in Cancer Research (2 papers). Mierzhati Mushajiang is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (5 papers) and HER2/EGFR in Cancer Research (2 papers). Mierzhati Mushajiang collaborates with scholars based in United States, South Korea and China. Mierzhati Mushajiang's co-authors include Pasi A. Jänne, Ciric To, Jaebong Jang, Nathanael S. Gray, Dries J.H. De Clercq, Eunyoung Park, Bo Hee Shin, Michael J. Eck, David E. Heppner and Thomas W. Gero and has published in prestigious journals such as Angewandte Chemie International Edition, European Journal of Medicinal Chemistry and Cancer Discovery.

In The Last Decade

Mierzhati Mushajiang

6 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mierzhati Mushajiang United States	6	384	329	295	102	45	6	547
Bo Hee Shin United States	7	344 0.9×	265 0.8×	259 0.9×	95 0.9×	45 1.0×	7	505
Dries J.H. De Clercq United States	8	409 1.1×	279 0.8×	280 0.9×	108 1.1×	56 1.2×	11	570
Stefanie Heynck Germany	6	228 0.6×	285 0.9×	249 0.8×	95 0.9×	28 0.6×	6	418
Shuhang Wang China	5	253 0.7×	375 1.1×	328 1.1×	91 0.9×	21 0.5×	8	539
Julian Engel Germany	11	290 0.8×	142 0.4×	154 0.5×	187 1.8×	36 0.8×	14	452
Stephen Wang United States	3	203 0.5×	196 0.6×	200 0.7×	52 0.5×	20 0.4×	3	321
L. Scarlett United Kingdom	4	281 0.7×	201 0.6×	331 1.1×	203 2.0×	35 0.8×	4	561
Xiao-E Yan China	9	173 0.5×	158 0.5×	139 0.5×	117 1.1×	37 0.8×	10	321
Jacob I. Contreras United States	10	344 0.9×	85 0.3×	195 0.7×	124 1.2×	20 0.4×	12	536
Jeff Kucharski United States	6	534 1.4×	94 0.3×	216 0.7×	86 0.8×	42 0.9×	10	656

Countries citing papers authored by Mierzhati Mushajiang

Since Specialization

Citations

This map shows the geographic impact of Mierzhati Mushajiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mierzhati Mushajiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mierzhati Mushajiang more than expected).

Fields of papers citing papers by Mierzhati Mushajiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mierzhati Mushajiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mierzhati Mushajiang. The network helps show where Mierzhati Mushajiang may publish in the future.

Co-authorship network of co-authors of Mierzhati Mushajiang

This figure shows the co-authorship network connecting the top 25 collaborators of Mierzhati Mushajiang. A scholar is included among the top collaborators of Mierzhati Mushajiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mierzhati Mushajiang. Mierzhati Mushajiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jang, Jaebong, Ciric To, Dries J.H. De Clercq, et al.. (2020). Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations. Angewandte Chemie International Edition. 59(34). 14481–14489. 108 indexed citations

2.

Jang, Jaebong, Ciric To, Dries J.H. De Clercq, et al.. (2020). Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations. Angewandte Chemie. 132(34). 14589–14597. 13 indexed citations

3.

To, Ciric, Jaebong Jang, Ting Chen, et al.. (2019). Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor. Cancer Discovery. 9(7). 926–943. 250 indexed citations

4.

Rangachari, Deepa, Ciric To, Paul A. VanderLaan, et al.. (2019). EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples. Journal of Thoracic Oncology. 14(11). 1995–2002. 69 indexed citations

5.

Clercq, Dries J.H. De, David E. Heppner, Ciric To, et al.. (2019). Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors. ACS Medicinal Chemistry Letters. 10(11). 1549–1553. 65 indexed citations

6.

Jang, Jaebong, Ciric To, Magda Bahcall, et al.. (2017). Discovery of a potent dual ALK and EGFR T790M inhibitor. European Journal of Medicinal Chemistry. 136. 497–510. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact